Rasagiline formulations and processes for their preparation

Details Rasagiline formulations and processes for their preparation Rasagiline formulations and processes for their preparation

2008-09-08

2009-10-06

Davis, Brian J (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

C564S308000, C564S437000

Reexamination Certificate

active

07598420

ABSTRACT:
The subject invention provides a pharmaceutical composition comprising N-propargyl-1(R)-aminoindan mesylate; a pharmaceutically acceptable carrier; and greater than 0.7 ppm but less than 30 ppm in total of a compound having the structure:and any salts of the compound.

REFERENCES:
patent: 5387612 (1995-02-01), Youdim et al.
patent: 5453446 (1995-09-01), Youdim et al.
patent: 5457133 (1995-10-01), Youdim et al.
patent: 5486541 (1996-01-01), Sterling et al.
patent: 5519061 (1996-05-01), Youdim et al.
patent: 5532415 (1996-07-01), Youdim et al.
patent: 5576353 (1996-11-01), Youdim et al.
patent: 5599991 (1997-02-01), Youdim et al.
patent: 5668181 (1997-09-01), Youdim et al.
patent: 5744500 (1998-04-01), Youdim et al.
patent: 5786390 (1998-07-01), Youdim et al.
patent: 5891923 (1999-04-01), Youdim et al.
patent: 6126968 (2000-10-01), Peskin et al.
patent: 6277886 (2001-08-01), Levy et al.
patent: 6316504 (2001-11-01), Youdim et al.
patent: 6462222 (2002-10-01), Chorev et al.
patent: 6630514 (2003-10-01), Youdim et al.
patent: 6635667 (2003-10-01), Thomas
patent: 6956060 (2005-10-01), Youdim et al.
patent: 7491847 (2009-02-01), Frenkel
patent: 2004/0010038 (2004-01-01), Blaugrund et al.
patent: 2004/0052843 (2004-03-01), Lerner et al.
patent: 2004/0127577 (2004-07-01), Blaugrund et al.
patent: 2005/0093830 (2005-05-01), Youdim et al.
patent: 2006/0018957 (2006-01-01), Lerner et al.
patent: 2006/0094783 (2006-05-01), Youdim et al.
patent: 2006/0188581 (2006-08-01), Peskin
patent: 2007/0100001 (2007-05-01), Youdim et al.
patent: 2007/0112217 (2007-05-01), Frenkel et al.
patent: 2007/0232700 (2007-10-01), Blaugrund et al.
patent: 2008/0146676 (2008-06-01), Frenkel et al.
patent: 2008/0161408 (2008-07-01), Frenkel et al.
patent: 0538134 (1993-04-01), None
patent: 0436492 (1994-06-01), None
patent: 9511016 (1995-04-01), None
patent: 9518617 (1995-07-01), None
patent: 9637199 (1996-11-01), None
patent: 9712583 (1997-04-01), None
patent: 9802152 (1998-01-01), None
patent: 03072055 (2003-09-01), None
patent: 2004045515 (2004-06-01), None
patent: 2006014973 (2006-02-01), None
patent: 2006057912 (2006-06-01), None
patent: 2008019871 (2008-02-01), None
patent: 2008131961 (2008-06-01), None
Kirk-Othmer Encyclopedia of Chemical Technology (2005), John Willy & Sons, Inc., vol. 18, entry: Pharmaceuticals, p. 33, No. 11.
Finberg et al. (1981) “Selective Irreversible Propargyl Derivative Inhibitors of Monoamine Oxidase (MAO) without the Cheese Effect”Chem. Abstracts94:202499.
Finberg and Youdim (1985) “Modification of Blood Pressure and Nictitating Membrane Response to Sympathetic Amines by Selective Monoamine Oxidase Inhibitors”Brit. J.Pharmac.85(2):541-546.
Finberg et al. (1985) “Modification of Blood Pressure and Nictitating Membrane Response to Sympathetic Amides by Selective Monoamide Oxidase Inhibitors, Types A and B, in the Cat”Chem. Abstracts103:81618.
U.S. Appl. No. 11/595,726, filed Nov. 10, 2006, Youdim et al.
Mendlewicz and M.B.H. Youdim (1983)Brit. J. Psychiat. 142:508-511.
Youdim MBH, et al., “Rasagiline (N-propargyl-1R(+)-aminoindan), a selective and potent inhibitor of mitochondrial monoamine oxidase B”,Br. J. Pharmacol., 2001, 132:500-6.
Youdim et al. in Handbook of Experimental Pharmacology vol. 90/I (1988) Chapter 3, Trendlenburg and Weiner, eds.
Youdim et al. (1984)Progress in Medicinal Chemistry21:138-167.
U.S. Appl. No. 11/600,561, filed Nov. 15, 2006, Frenkel et al.
U.S. Appl. No. 11/634,916, filed Dec. 6, 2005, Sterling et al.
U.S. Appl. No. 11/791,684, filed May 24, 2007, Patashnik et al.
U.S. Appl. No. 12/002,082, filed Dec. 12, 2007, Anton Frenkel and Tamas Koltai.
U.S. Appl. No. 12/223,794, filed Aug. 7, 2008, Poewe et al.
U.S. Appl. No. 12/283,946, filed Sep. 16, 2008, Lendvai et al.
U.S. Appl. No. 12/231,601, filed Sep. 3, 2008, Oron et al.
U.S. Appl. No. 12/283,022, filed Sep. 8, 2008, Sterling et al.
U.S. Appl. No. 12/283,107, filed Sep. 8, 2008, Sterling et al.
Scientific Discussion (EMEA 2005), http://www.emea.europa.eu/humandocs/PDFs/EPAR/Azilet/528970en6.pdf, published Mar. 17, 2005, especially p. 9.
Office Action issued Mar. 5, 2009 in the U.S. Appl. No. 12/283,022.
Office Action issued Mar. 24, 2009 in the U.S. Appl. No. 12/283,107.
Paquette, L. A. et al. “1.5-Asymmetric Induction in Squarate Cascades Conformational Control of Helicity by Chiral Amino Substituents during Conrotatory Octatetraene Cyslization Prior to Elimination”, J. Org. Chem., 1998, 63(6), 2022-2030.
Office Action issued Jul. 11, 2008 in the U.S. Appl. No. 11/634,916.
Office Action issued May 2, 2008 in the U.S. Appl. No. 11/634,916.
Paquette, L. A. et al. “1,5-Asymmetric Induction in Squarate Cascades Conformational Control of Helicity by Chiral Amino Substituents during Conrotatory Octatetraene Cyslization Prior to Elimination”, J. Org. Chem., 1998, 63(6), 2022-2030.

Affiliated with

Also associated with

Rating

Rasagiline formulations and processes for their preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rasagiline formulations and processes for their preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rasagiline formulations and processes for their preparation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4129465